Synapse - Works

Results (2639)

A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory B-cell malignancies

Meeting Abstract

Park, J. H.; Riviere, I.; Sikder, D. S.; Bermudez, V. P.; Senechal, B.; Wang, X.; Auchincloss, T. H.; Diamonte, C.; Halton, E.; Palomba, M. L.; more...
Blood (2020)

Fulltext@MSK | Save

Safety and preliminary efficacy in patients with relapsed/refractory mantle cell lymphoma receiving lisocabtagene maraleucel in TRANSCEND NHL 001

Meeting Abstract

Palomba, M. L.; Gordon, L. I.; Siddiqi, T.; Abramson, J. S.; Kamdar, M.; Lunning, M. A.; Maloney, D. G.; Andreadis, C.; Arnason, J. E.; Ghosh, N.; more...
Blood (2020)

Fulltext@MSK | Save

Safety, pharmacokinetics and activity of CA-4948, an IRAK4 inhibitor, for treatment of patients with relapsed or refractory hematologic malignancies: Results from the phase 1 study

Meeting Abstract

Nowakowski, G. S.; Leslie, L. A.; Younes, A.; Rosenthal, A. C.; Lunning, M. A.; Patel, K.; Landsburg, D. J.; Martinez, E.; von Roemeling, R.; Lieberman, C.; more...
Blood (2020)

Fulltext@MSK | Save

Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial

Meeting Abstract

Musiek, A. C. M.; Whittaker, S.; Horwitz, S. M.; Bagot, M.; Huen, A.; Fisher, D. C.; Haun, P.; Vermeer, M. H.; Ito, T.; Dwyer, K.; more...
Blood (2020)

Fulltext@MSK | Save

R-CHOP versus R-Bendamustine with or without rituximab maintenance in newly diagnosed follicular lymphoma patients with high SUV at baseline PET

Meeting Abstract

Mondello, P.; Strati, P.; Merryman, R. W.; Joffe, E.; Ruella, M.; Seshan, V.; St Pierre, F.; Major, A.; Pophali, P.; Fiasconaro, M.; more...
Blood (2020)

Fulltext@MSK | Save

Phase II study of pembrolizumab plus GVD as second-line therapy for relapsed or refractory classical Hodgkin lymphoma

Meeting Abstract

Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Hancock, H.; Davey, T.; Sohail, S.; Santarosa, A.; Pomerantz, L.; Jarjies, C.; more...
Blood (2020)

Fulltext@MSK | Save

Successful treatment of mature T-cell lymphoma with allogeneic stem cell transplantation: The largest multicenter retrospective analysis

Meeting Abstract

Mehta-Shah, N.; Kommalapati, A.; Teja, S.; Cashen, A. F.; Dahi, P. B.; Sauter, C. S.; Moskowitz, A. J.; Jacobsen, E. D.; William, B. M.; Ozga, M.; more...
Blood (2020)

Fulltext@MSK | Save

End of treatment peripheral blood T-cell receptor gene rearrangement evaluation for minimal residual disease evaluation in peripheral T-cell lymphomas

Meeting Abstract

Mehta-Shah, N.; Fehniger, T. A.; Jacobsen, E. D.; Peterson, K.; Kahl, B. S.; Bartlett, N. L.; Cashen, A. F.; Ghobadi, A.; Fischer, A.; Reagan, B.; more...
Blood (2020)

Fulltext@MSK | Save

Interim positron emission tomography (iPET) assessed using Deauville score for patients with follicular lymphoma receiving first-line chemoimmunotherapy

Meeting Abstract

Merryman, R. W.; Spilberg, G.; Mondello, P.; Redd, R. A.; Taranto, E.; Ahmed, G.; Jeter, E.; Chase, M.; Salles, G.; Zelenetz, A. D.; more...
Blood (2020)

Fulltext@MSK | Save

Subcutaneous mosunetuzumab in relapsed or refractory B-cell lymphoma: Promising safety and encouraging efficacy in dose escalation cohorts

Meeting Abstract

Matasar, M. J.; Cheah, C. Y.; Yoon, D. H.; Assouline, S. E.; Bartlett, N. L.; Ku, M.; Giri, P.; Johnston, A.; Flinn, I. W.; Goy, A. H.; more...
Blood (2020)

Fulltext@MSK | Save